Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
about
Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesExosomes as miRNA Carriers: Formation-Function-FutureRecent advances in hepatocellular carcinoma therapy.The feasibility of using mutation detection in ctDNA to assess tumor dynamics.A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysisA serum 6-miRNA panel as a novel non-invasive biomarker for meningioma.Release of extracellular vesicles containing small RNAs from the eggs of Schistosoma japonicum.Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns StudyCirculating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver FibrosisCirculating microRNAs as Potential Biomarkers of Infectious Disease.Exosomes: small vesicles with big roles in hepatocellular carcinoma.Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma.Increased Circulating Exosomal miRNA-223 Is Associated with Acute Ischemic Stroke.Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.Exosomes in liver pathology.Role of circulating microRNAs in liver diseasesExtracellular miRNAs as biomarkers in cancer.MicroRNAs in extracellular vesicles: potential cancer biomarkers.The choice of endogenous controls in exosomal microRNA assessments from biofluids.Emerging role of exosomes in liver physiology and pathology.The Use of Exosomes as Biomarkers for Evaluating and Monitoring Critically Ill Polytrauma Patients with Sepsis.MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.Extracellular vesicles in liver diseases.The role of exosomes and miRNAs in drug-resistance of cancer cells.Exosomal miRNAs as biomarkers in the diagnosis of liver disease.Exosomes: New players in cancer (Review).Identification of the novel 3' UTR sequences of human IL-21 mRNA as potential targets of miRNAs.Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.MiR-101 inhibits ovarian carcinogenesis by repressing the expression of brain-derived neurotrophic factor.High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma.Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis.Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles.Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.
P2860
Q26743361-3423D7D4-B9C1-4F29-BE73-48D70D7D0C73Q26748881-EE911A25-4BA6-49B7-A656-C3A075632EFDQ28075728-52E4F57B-8D13-47AE-8D4C-064FE140A67FQ30236010-A0E9A1BD-2930-4262-AAE2-9EEB7B313BFAQ33697983-8ED62BC4-2FDD-4871-95A1-1FB2B88AC6BFQ33853938-3BD0EF69-78AB-4E2B-82BC-E7F1D4E5047DQ37202515-2F76D31C-E152-4E3E-BC4D-07CE9D6642F2Q37402882-223A54B3-8AAD-4934-9D78-42B1C38FA3EAQ37472354-137F9131-E88D-4D53-962E-32B72FA6BA62Q37632907-683D032A-C1FC-4285-9322-0429F65D901FQ37643903-245A2DF0-D1B2-45FE-901E-B494AAEEA6A2Q37645086-45BBD0BF-8F3F-4A12-9A1B-5644BA2EF6FBQ37654423-06951866-830E-4067-B2F7-535EB7D90C98Q37667327-421BCE56-4DFE-4B20-8BBD-FFB7F440074EQ38432667-A00D0F29-C9F9-477C-8437-492F72B43738Q38632868-B72830B3-5854-4432-BCC9-62FF1664A3E8Q38742581-C4742202-7F0F-419C-94EC-1C7B8BE2F243Q38770935-0994D062-1ED1-47FD-B545-F27E21ACEEB5Q38779087-570A17A4-5391-4616-9CC9-DA80C448062FQ38779843-AD1F41F0-5205-49CD-B205-B7C094750CF4Q38867417-F549DFD7-F8A4-43F9-928A-0E576C870636Q38887851-AEA8D79F-A329-44C9-B135-75F2E41570E5Q38903386-BB0D377A-2943-4D77-9637-957D4D22D717Q38931228-933CF082-AE26-4B6A-8A53-9DA99B74F147Q38950417-341519AD-F15B-4C36-BA4A-BC662833AB7DQ39030840-87F39897-B3E0-499D-B11E-B63759BA293CQ39041043-8D5954EF-6D2B-4B47-8722-B948D28336DFQ39063293-A3401E40-1C81-4645-AA05-DF158E4D0CC8Q39152624-DC31381C-AC12-46F5-81FB-D2A657730036Q39361895-9C829725-2FAB-486A-A289-A1B0ED16A8FBQ39382436-D4FC8FDB-38C6-40E8-9454-182D3AC9474DQ40086494-112489C7-71DE-47AB-9DC7-87FA3620E3A2Q41283812-DF142709-C7DF-4E9E-A7F4-CBCD74A10959Q41505555-7793B3EC-AD38-4666-92D7-9923BCEAFD5AQ41627612-6F04446E-8464-4D24-A4EA-347C83CB7095Q42365746-EB728B64-6EB9-41C4-8698-D41325E5FB73Q47097478-5618EABB-4042-481E-BB67-D81761EC94EEQ47109252-3E622234-BF05-4352-9F0D-AA58F0B24BD6Q47250358-8D7F1BED-23E8-4478-B272-49CC2E9C470FQ47419610-F6561AC1-2277-4823-BA78-56529F6B8E95
P2860
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
@ast
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
@en
type
label
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
@ast
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
@en
prefLabel
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
@ast
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
@en
P2093
Hyun Chin Cho
Jonghwa Kim
Ju-Yeon Cho
Sang Goon Shim
Se Ra Yang
So Hee Kang
Yong-Han Paik
P2860
P2888
P356
10.1038/EMM.2015.68
P577
2015-09-18T00:00:00Z